OneSource

Stelis Biopharma is a leading Contract Development and Manufacturing Organization (CDMO) that specializes in the production of biologics, which are drugs derived from living organisms. The company serves a broad range of clients, including top biopharmaceutical companies, and operates primarily in the Asia-Pacific (APAC) region, where it boasts one of the highest CDMO capacities.

Stelis Biopharma's business model revolves around supporting the entire lifecycle of a biologic product, from development to market. This includes the production of both drug substances and drug products. The company operates two state-of-the-art facilities in Bangalore, India, which together offer around 85,000 square meters of process development and manufacturing space. These facilities are equipped to handle a variety of production modalities, including mammalian and microbial processes.

The company generates revenue by providing end-to-end product development and manufacturing services. This includes small-scale clinical and commercial manufacturing, as well as quality control. Stelis Biopharma prides itself on its commitment to quality and regulatory compliance, and its facilities have been designed in consultation with international regulatory agencies, including the US Food and Drug Administration (FDA).

In summary, Stelis Biopharma is a trusted partner in the biopharmaceutical industry, offering comprehensive product development and manufacturing services. The company's commitment to quality, regulatory compliance, and client collaboration sets it apart in the competitive CDMO market.

Keywords: Biopharmaceuticals, Contract Development and Manufacturing Organization (CDMO), Biologics, Asia-Pacific (APAC) region, Product Lifecycle, Drug Substances, Drug Products, Quality Control, Regulatory Compliance, Client Collaboration.